NCT04231110View on ClinicalTrials.gov

Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

November 18, 2024

Study Completion Date

November 18, 2024

Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL

Fecal microbiota transplantation

Use of fecal microbiota transplantation enemas once weekly in patients who are initiating vedolizumab treatment

Trial Locations (1)

L8S4K1

Hamilton Health Sciences, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER